ERT launches enhanced platform to streamline data collection, analysis and processing

Friday, September 7, 2012 11:57 AM

ERT, a global technology-driven provider of health outcomes services, has launched an enhanced clinical research workflow technology designed to streamline data collection, analysis and processing in clinical trials.

The new offering, which comprises the Expert3 workflow platform and MyStudyPortal3 reporting engine, can simultaneously process health outcomes data across cardiac safety, clinical outcome assessment (COA)/ePRO and respiratory studies. The integrated platform offers users a simple way to process multiple types of data accurately, leading to fewer errors in studies, and as a result, shorter lead times. The enhanced solution can help sponsors, CROs and trial sites facilitate informed decision making throughout the drug development process, and also provides evidence and support for product approvals and labeling claims.

Built on ERT’s Expert technology that underpins all of ERT’s data acquisition, analysis and reporting, the new integrated platform can support more studies concurrently and is able to process a combination of data seamlessly across multiple therapy areas. The solution also supports a full suite of COA/ePRO, cardiac safety and respiratory devices, as well as a range of clinical endpoint devices such as glucometers and activity monitors. As the customer interface for Expert3, MyStudyPortal3 is an easy-to-use web interface which enables users to view trial data generated by Expert3 on demand and in real time from anywhere in the world. By implementing the solution, users can view all important information relating to a trial and receive instant online support relating to the data generated.

“As the industry continues to search for ways to produce the most accurate data possible, this enhanced solution will enable clinical researchers to make better timely decisions relating to the progression of their studies, reducing the economic and time burden of unsuccessful studies and compounds, and ultimately, helping pharmaceutical companies to improve the development of new drugs,” said Jeffrey Litwin, CEO of ERT.

Expert3 provides a validated platform to customize trials workflows to collect various outcome endpoints through a single interface. The highly configurable tool provides the ability to leverage client specific standards to facilitate the study set up process using validated and proven tools which drives quality across various studies within a program.

MyStudyPortal3 has been developed to make sites more independent by providing a platform to manage results from multiple data streams as well as reduce the burden of site administrative tasks through an interactive portal. Features include capability to resolve queries through instant online support, order trial supplies and view reference material, analyze clinical endpoints and implement customized alerts. In addition, study data only takes 30 seconds to populate, allowing for fast data collection and any abnormal data to be identified and reported straight away, resulting in less redundant information.

Share:          
CWWeekly

April 20

Christie Clinic, PMG Research's 12th clinical research site, expands its geographic reach north to Illinois

Clinipace acquires Accovion to expand European presence, following an infusion of equity that could lead to more deals

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs